InforCapital

Healthcare Private Equity Firms in Europe

76 investors found

Browse 76 Healthcare Private Equity Firms in Europe. Discover top investors, their portfolios, AUM, and investment focus on InforCapital.

1788 Capital Trust

1788 Capital Trust

InvestorSwitzerland500M AUM

1788 Capital is a privately-owned Swiss investment manager, founded in 2013, dedicated to serving entrepreneurs and international families. The firm focuses on delivering high-performance results, positive impact, and sustainability in its investment strategies. They offer comprehensive wealth management and multi-family office services, emphasizing capital preservation, absolute return strategies, and an open architecture approach. Their investment interests span various sectors, including education, climate change, sustainable agriculture & nutrition, health & well-being, and clean transportation, alongside private equity and real estate opportunities.The firm was established in 2013 by its founders and managers, operating independently from any bank or financial institution. Headquartered in Geneva, Switzerland, with a representative office in London, 1788 Capital aims to provide fully independent investment advisory services with a strong ethical framework, ensuring excellence in operations and client privacy.1788 Capital actively sources private investment opportunities, including private equity funds, start-ups, club deals/co-investments, real estate, real assets, and alternative funds. The team is deeply involved in the assessment, due diligence, and M&A processes for each opportunity, followed by operational monitoring. They also assist clients with strategic financings, managing complex negotiations with top-tier financial institutions for various assets like real estate, private equity, unlisted shares, aircrafts, or yachts.The team at 1788 Capital comprises highly qualified and trusted investment and family office professionals. These individuals have extensive experience in managing significant assets and supervising private wealth strategies within globally respected finance institutions, banks, and family-owned companies. The firm leverages its unique multi-national expertise and a well-established worldwide network of professional specialist partners to offer comprehensive advice on legal, taxation, financing, charitable vehicles, trust management, private equity, real estate, aviation, and art.

2PointZero

2PointZero

InvestorUnited Arab Emirates36.2B AUM

2PointZero Group PJSC is a next-generation investment powerhouse based in Abu Dhabi, United Arab Emirates. The firm focuses on two multi-trillion-dollar sectors: Energy and Consumer, which are fundamental to everyday life and the new economy. Leveraging an AI-enabled, diversified portfolio, 2PointZero aims for efficiency, synergy, and compounding returns, driving sustainable growth through disciplined capital allocation, operational excellence, and digital integration. The firm's investment strategy is global, seeking opportunities to catalyze profitable growth through technology across its various business verticals.The current entity, 2PointZero Group PJSC, was formed in 2023 through a significant consolidation of major Abu Dhabi platforms, including Multiply Group and Ghitha Holding, under the umbrella of International Holding Company (IHC). The company officially changed its name from Multiply Group PJSC to Two Point Zero Group P.J.S.C in November 2025. This strategic restructuring aimed to create a robust and diversified investment platform with substantial assets, positioning it for transformative impact globally.2PointZero has made several notable investments and acquisitions. In March 2026, the firm completed a majority acquisition in Italy-based ISEM Packaging Group, a leading European packaging company serving luxury, beauty, and food sectors. The same month, its subsidiary IRH secured a 20-year LNG supply from Mexico's AMIGO LNG Project, and the group invested in WHOOP's Series G financing, a prominent consumer health and wellness technology platform. Additionally, 2PointZero acquired a 100% stake in Traverse Midstream Partners LLC, a US natural gas infrastructure firm, further expanding its energy portfolio in North America.The firm's leadership includes Sheikh Zayed bin Hamdan bin Zayed Al Nahyan as Chairman and Samia Bouazza as CEO. 2PointZero emphasizes the disciplined use of AI and advanced data capabilities to enhance decision-making, unlock new revenue streams, and ensure efficient, responsible growth across its extensive portfolio. The group's strategic focus spans high-growth sectors, including food security, advanced energy, and renewables, with plans to capitalize on demographic shifts and rising demand for consumer goods in emerging markets.

ACP Partners

ACP Partners

InvestorBritish Virgin Islands

ACP Partners is an investment firm that provides capital solutions for growth, restructuring, acquisition finance, and liquidity to family businesses and entrepreneurs. The firm's philosophy emphasizes long-standing relationships and partnerships, with investments often stemming from shared values and ambitious projects with talented entrepreneurs and their management teams. They currently lead the investment activities of a Single Family Office and manage a portfolio of legacy co-investments.The firm was co-founded by Alok Oberoi in 2001, initially operating under the trade name ACPI, functioning as a family office and a co-investment platform for proprietary investments. Following a restructuring in December 2018, which involved the sale of ACPI’s wealth management business, the Principal Investments division was re-launched as ACP Partners. This re-launch marked a strategic shift to focus on direct investment activities for a single family office and the realization of existing co-investments.While specific portfolio companies are not extensively detailed on their website, PitchBook indicates an investment in IndiaLends in both 2018 and 2021. The firm's investment approach is broad, seeking opportunities across various industries and geographies, with a focus on providing tailored capital solutions rather than specializing in a narrow sector.The ACP Partners team is described as strong and stable, carefully built by Alok Oberoi over a decade, embodying a family ethos. Key team members include Jaideep Puri, who heads the investment team and has a background in financial solutions, structured financing, and direct lending, having deployed over US$1 billion in capital across diverse sectors. Alok Oberoi, a co-founder, serves as a Consultant for ACP Partners and is also the Executive Chairman at Everstone Capital Asia, bringing extensive experience from his 14-year career at Goldman Sachs. William Watson, another Director, has experience in investment banking at Citigroup and currently holds an Executive Director role at Everstone Group in Dubai, focusing on special situations and business development, with prior experience in tech services and healthcare investments in Singapore.

Admaius Capital Partners

Admaius Capital Partners

InvestorRwanda

Admaius Capital Partners is a pan-African private equity firm focused on high-impact sectors including digital infrastructure, financial services, fast-moving consumer goods (FMCG), healthcare, and education to drive social and economic transformation across Africa. The firm targets businesses with potential for digital transformation, providing patient capital, operational support, and expertise to scale operations, expand internationally, and create long-term value. With a strong emphasis on ESG principles and responsible investing, Admaius blends local market knowledge with global experience to attract new international capital into African private equity opportunities.

Advent International

Advent International

InvestorBrazil94.0B AUM

Founded in 1984, Advent International is one of the largest and most experienced global private equity firms. With decades of industry leadership, it has established a strong track record of successful investments and deep sector expertise. Advent has invested in over 420 private equity transactions across 43 countries. The firm partners with management teams to accelerate growth through strategic support, operational improvement, and long-term vision alignment. With $94 billion in assets under management as of December 31, 2023, Advent primarily focuses on buyouts and growth equity investments across five key sectors, maintaining a flexible and globally integrated approach.

A

Altur Investissement

InvestorFrance37M AUM

Altur Investissement is a single-family office and investment firm based in Paris, France, managing the assets of the Lombard family. Established in 2006 by François Lombard, the founder of Turenne Capital, the firm operates with a platform model, aiming to support growing companies with strong management teams in a climate of trust. Altur Investissement engages in various investment strategies, including acting as Limited Partners (LPs) in funds, participating in co-investments, making direct investments, and sponsoring new funds.The firm's investment philosophy is characterized by a long-term approach, seeking to be active partners with their portfolio companies to foster growth. Altur Investissement focuses on profitable companies, taking both majority and minority stakes. Their direct investment criteria typically involve companies with a turnover between €2 million and €20 million, with investment tickets ranging from €1 million to €5 million. They also demonstrate flexibility to explore other sectors and asset types when deemed relevant.Altur Investissement has a track record of accompanying over 50 companies, with notable success stories including Webhelp, Menix, Completude-Kinougarde, and Biobank. More recently, their portfolio includes investments in companies like ARTFX, Vizcab, and Formavenir Performances, spanning sectors such as educational services and multimedia software. The firm's portfolio, as of late 2022, amounted to €37.21 million, with significant allocations to healthcare, energy transition, and hospitality.The leadership team includes François Lombard as the founder and manager, alongside Rémy Lombard and Bertrand Cavalié, who serve as Deputy CEOs. The team brings diverse expertise, with backgrounds in strategy consulting, MedTech, PropTech, and financial analysis, enabling Altur Investissement to provide active support and sector-specific knowledge to its investments.

Ansor Capital

Ansor Capital

InvestorUnited Kingdom630M AUM

Ansor LLP is a London-based private equity firm focused on acquiring and growing small and medium-sized enterprises (SMEs) in fragmented, high-growth sectors across the UK. Founded in 2010 by Edward Ainsworth, Peter Marson, and Peter Strafford, Ansor has established a reputation for building market-leading businesses through strategic acquisitions and operational excellence. The firm employs a data-driven approach to identify attractive subsectors with long-term growth potential, profitability, and fragmentation. Ansor's investment strategy involves creating platform companies and executing buy-and-build strategies to consolidate these sectors. Notable investments include ALS Dental, Compliance Group, and 21 Degrees Group, among others. Ansor has successfully raised and deployed multiple funds, including Ansor Fund I and the oversubscribed Ansor Fund II, which closed at its hard cap of £250 million in April 2025. The firm's commitment to sustainability is evident, with all portfolio companies striving for carbon neutrality. Ansor's experienced team continues to drive value creation through strategic investments and operational improvements.

Applied Value Group

Applied Value Group

InvestorUnited States

Applied Value Group is a global management consulting firm that specializes in driving value creation and organizational transformation through a hands-on, results-oriented approach. The firm operates with a "Lean Growth" philosophy, focusing on delivering tangible financial impact and measurable results for its clients. Beyond traditional consulting, Applied Value Group also engages in private and public investments, acquiring majority or minority stakes in businesses, and maintains a strong commitment to social impact initiatives.The firm's history dates back to 1997, when it was founded by Bruce Grant and his long-time partner Jan Stenbeck, head of the Stockholm-based Kinnevik Group. Their vision was to establish a consultancy that moved beyond mere presentations, instead focusing on delivering concrete financial value and demonstrable impact. Initially conceived as a hybrid external and internal management consultancy, Applied Value Group has evolved into a fully independent boutique firm with a global footprint, serving a diverse clientele that includes Fortune 500 companies and private equity firms across various industries.Applied Value Group's practice areas encompass Strategy, Finance & Organization; Sales, Marketing & Growth; Supply Chain & Operations; Sourcing & Procurement; Product & Innovation; and Mergers & Acquisitions. They advise and invest across a wide array of sectors, including automotive, industrials, telecommunications, technology, healthcare, manufacturing, and consumer goods. The firm's investment activities often involve applying its consulting methodologies to improve the operational efficiency and growth of its portfolio companies. In August 2025, Applied Value Group received a strategic growth investment from Trivest Partners, a private equity firm, to further scale its offerings and expand its global reach.The team at Applied Value Group is characterized by an intense, entrepreneurial culture that values decisive, highly motivated, and results-oriented consultants. They emphasize early responsibility, a supportive network, and a global working environment, providing opportunities for professional development across their consulting, investment, and social impact practices. The firm seeks candidates with strong business acumen, financial skills, and a willingness to travel, fostering a flat organizational structure where exceptional ideas are recognized at all levels.

AQAL Capital

AQAL Capital

InvestorGermany

AQAL Capital is a Munich-based investment firm specializing in "Integral Investing," an approach that combines rigorous financial due diligence with social, environmental, cultural, and ethical considerations. The firm focuses on state-of-the-art exponential technology companies that demonstrate potential for substantial growth and integral impact, aligning with the UN Sustainable Development Goals (SDGs) within planetary boundaries. They target seed and early-stage companies with strong leadership, proven technology, and a short runway to cash flow break-even.Founded in 2014, AQAL Capital was established by Dr. Mariana Bozesan and Thomas Schulz. Dr. Bozesan, an award-winning integral investor and serial entrepreneur, has been actively involved in venture capital and entrepreneurship since 1995. The firm's philosophy, deeply rooted in Dr. Bozesan's "Integral Investing: From Profit to Prosperity" report to the Club of Rome, aims to leverage exponentially growing technologies to address global grand challenges and foster a sustainable global society.AQAL Capital has a diverse portfolio of investments across various high-tech sectors. Notable past and current investments include CyberNet AG, one of Germany's first publicly traded internet companies; Entelios AG, a German demand response aggregator; and Penumbra, a medical device company specializing in neurovascular diseases. More recent investments include Green Spot Technologies, CrowdSmart, XO Life, Kipu Quantum, and Proxima Fusion, spanning specialty chemicals, business software, healthcare services, and alternative energy.The AQAL Capital team, led by its founders, brings extensive experience to the investment landscape, combining over 95 years of private equity and venture capital expertise, 65 years in impact investing and venture philanthropy, and 95 years of entrepreneurship know-how. Their deep sector knowledge spans exponential technology & AI, renewable energy and clean technology, medical devices, and healthcare. The team is actively involved in global initiatives, including the Club of Rome and the UN Principles for Responsible Investing (UN PRI), demonstrating a commitment to addressing global challenges through responsible venture investing.

Aquasourca

Aquasourca

Limited PartnerFrance250M AUM

Aquasourça is a family-owned investment firm with permanent capital, actively engaged in both private equity and real estate. The firm employs two distinct private equity strategies: a generalist approach for growth investments across various industries and services, and a sector-specific focus, particularly in the agri-food sector. In real estate, Aquasourça pursues complementary strategies, including value-add for development activities and core/core+ for real estate asset management, primarily in France and Europe, with co-investments globally. The firm emphasizes a highly entrepreneurial approach, providing financial expertise and tailored support to foster the growth of its portfolio companies.The company was founded in 1996 by Sophie Defforey, stemming from a unique entrepreneurial opportunity in the water sector, which also inspired its name. Building on this initial success, Sophie Defforey structured Aquasourça with the vision of supporting business leaders in their development projects. The firm operates with its own funds, allowing for patient capital, long-term partnerships, and a streamlined decision-making process.Aquasourça has a diverse portfolio, having made over 60 investments and 26 exits. Notable investments span industries such as logistics (LSO (Merville)), industrials (Vestal Groupe), and various companies in the business, food, consumer products, and services sectors. The firm typically commits between €3 million and €15 million per operation, taking active minority or majority positions in profitable companies with strong organic and external growth potential.The Aquasourça team is composed of experienced professionals, including Sophie Defforey as President, and a multidisciplinary group with expertise in investments, asset management, finance, and business development. The firm's approach is rooted in trust, respect, and shared values, aiming to build strategies that serve the company's project while respecting the experience and decisions of the leaders. They also integrate Environmental, Social, and Governance (ESG) considerations into their investment process, assisting entrepreneurs in implementing sustainable strategies.

Arcano Partners

Arcano Partners

InvestorIreland13.0B AUM

Arcano Partners, founded in 2003, is an independent international financial advisory and alternative asset management firm headquartered in Madrid, Spain. It operates across four core business lines: Investment Banking, Asset Management (including Private Equity, Credit, Real Estate, Sustainable Infrastructure, Venture Capital, and Aviation Finance), Asset Finance, and Research & Strategic Advisory. The firm is recognized for its Merchant-Banking model and emphasis on sustainable, responsible investing. With over €12 billion in assets under management and advisory since inception, Arcano’s Asset Management arm focuses on primary, secondary, and co-investment opportunities in mid-market private funds and companies in Europe and the U.S. The firm has more than 250 professionals supporting more than 400 funds and 3,000 underlying companies. It is also a signatory to the UN PRI, reflecting its ESG commitment. Arcano is structured around a partnership model with offices in major European and U.S. financial hubs. Its approach combines high-level M&A advisory, specialist credit & asset financing, macroeconomic research, and tailor-made private markets solutions. The firm also ranks among the top 10 global managers in private equity secondaries, according to the HEC Paris–Dow Jones ranking.

Astorg

Astorg

InvestorFrance24.0B AUM

Astorg is a leading pan-European private equity firm founded in 1998, managing over €24 billion in assets. The firm partners with entrepreneurs and management teams to acquire market-leading global companies, providing strategic guidance, governance, and capital to achieve growth goals. Astorg operates with a distinct entrepreneurial culture, a long-term shareholder perspective, and a lean decision-making body. With offices in Luxembourg, London, Paris, New York, Milan, and Frankfurt, Astorg has valuable industry expertise in healthcare, software, technology, business services, and technology-based industrial companies. The firm's investment approach emphasizes the "art of listening," fostering genuine partnerships and uncovering value through respectful dialogue. Astorg's investment strategy focuses on mid-sized European companies, often family-owned, combining operational success with entrepreneurial drive. The firm specializes in leveraged build-ups, growth capital, family transmissions, mid-cap owner and leveraged buyouts, and corporate spin-offs. Astorg's commitment to sustainability and ESG principles is evident in its participation in industry initiatives like the ESG Data Convergence Project.

AT Capital Group

AT Capital Group

Limited PartnerSingapore2.5B AUM

AT Capital Group is a prominent family office headquartered in Singapore, specializing in actively managed businesses and passive financial investments. The firm distinguishes itself from traditional private equity models by deploying its own funds, which grants it full autonomy over investment choices and durations. AT Capital Group focuses on creating value for all stakeholders by investing in sustainable businesses and taking an active role in their strategic management, leveraging its domain knowledge and global networks to help companies achieve their full potential.The firm was founded by Mr. Arvind Tiku, whose family trust is the sole owner of AT Capital Group. Mr. Tiku is an experienced entrepreneur and investor with a background in building international businesses across various sectors. While the exact founding year of the broader family office is not explicitly stated on its website, the legal entity, AT Capital Pte. Ltd., was established in 2011. The group maintains a significant global presence with over 400 employees and offices in India, Singapore, Dubai, and the Netherlands.AT Capital Group's investment strategy targets both public market securities, including debt, equity, metals, and other liquid assets, and strategic mid- to long-term investments. Its primary focus areas include Real Estate, Renewable Energy, Private & Structured Credit, and Public Markets. The firm also actively evaluates venture capital opportunities in high-potential startups and promising young companies, with recent portfolio additions such as BlueStone, Frendy, and ObvioHealth. Their real estate portfolio spans various geographies, including India, Europe, and the US, encompassing green-field development projects, commercial and retail assets, and supermarkets. Notable European real estate investments include projects in Amsterdam, Rijswijk, Haarlem, Paris, and Warsaw.The team at AT Capital Group comprises experienced professionals with diverse backgrounds in investment and finance. Key individuals include Arvind Tiku as Founder and Group Chairman, Sanjay Bakliwal as Director with extensive experience in real estate, financial services, and renewable energy, and Hywel Phillip as General Counsel. The firm is committed to ethical business practices, robust corporate governance, and environmental and social responsibility, aligning its ESG principles with the United Nations-backed framework for Principles for Responsible Investment.

A

Aurelius Global

InvestorNetherlands

Aurelius Global is a family office based in Amsterdam, Netherlands, established in 2021. The firm operates with a patient capital investment model, aiming to foster a brighter future through its strategic investments. They are dedicated to identifying and supporting transformative ideas across key sectors, extending beyond traditional market boundaries.The firm's investment focus is primarily on the Healthcare, Sustainability, Energy, and Education sectors. Aurelius Global emphasizes building robust partnerships and employs a hands-on approach to steer the success of its ventures, striving to realize the full potential of each investment. Their global team combines financial acumen with deep knowledge of emerging industries, enabling them to act decisively and innovatively.While specific notable investments and portfolio companies for this particular Aurelius Global family office are not extensively detailed in public records, PitchBook indicates an investment in Aave on November 4, 2022, within the Financial Software industry. This suggests a potential interest in the intersection of finance and technology, aligning with their broader focus on transformative ideas.The team at Aurelius Global is characterized by its blend of financial expertise and profound understanding of the sectors in which they invest. They are committed to operational engagement, providing support to their portfolio companies to enhance performance and drive growth. The firm's leadership and team are geared towards disciplined execution and a global perspective in their investment strategies.

Axon Partners Group

Axon Partners Group

InvestorSpain721M AUM

Axon Partners Group is a global investment and consulting firm that focuses on technology and innovation. The firm operates with a dual approach, offering both investment management and strategic consulting services. They partner with visionary leaders to drive innovation and create value in the technology sector, while their consulting arm provides insights and expertise for strategic, commercial, policy, and investment decisions. Axon Partners Group emphasizes effective strategies and investments to leverage innovative technologies for a better world.Founded in 2006 by Francisco Velázquez, Axon Capital and SVP Advisors initially operated as two separate entities in Madrid. Axon Capital focused on tech transfer venture capital, aiming to extract value from university technologies in Spain, and secured its first tech transfer VC fund in July 2007. SVP Advisors, on the other hand, extended Velázquez's consulting experience internationally. In 2012, Axon Capital and SVP Advisors merged to form Axon Partners Group, expanding their team and global reach. The firm successfully completed an IPO and was listed on the Madrid Stock Exchange, raising approximately €12 million.Axon Partners Group has a diverse portfolio with investments in various technology-driven companies. Recent investments include Dynamics VR, ISAAC (Construction and Engineering), and Grodi (Agriculture). The firm has also invested in companies like Taalentfy, a technology platform for employability and career guidance, and Odders, an XR company specializing in virtual reality games and applications. Other notable investments include Metricool, Instaleap, and W•SENSE. Axon Partners Group has also made 43 exits, with its latest being from Dogfy Diet in October 2025.The firm's team comprises over 100 seasoned professionals across its Consulting and Investment divisions, with diverse backgrounds and nationalities. This international team combines multi-sector tech expertise with a proven investment and advisory track record, aiming to deliver the agility of a boutique firm with the capabilities of a global company. Key management includes Francisco Velázquez as Chairman and Managing Partner, and Alfonso de León and Dimitri Kallinis as Managing Partners and Board Members.

B-FLEXION

B-FLEXION

InvestorSwitzerland27.2B AUM

B-FLEXION is a private, entrepreneurial investment firm that collaborates with sophisticated capital to achieve the shared objective of delivering exceptional value across generations, while also making a positive contribution to society. The firm operates with an 'active owner' philosophy, overseeing growth-oriented operating businesses and asset managers. Its investment scope encompasses partnering with asset managers across diverse sectors, including Private Equity, Venture Capital, Infrastructure, Technology, Real Estate, Hedge Funds, Public and Private Credit, and Public Securities.Building upon its rich heritage, B-FLEXION also actively expands operating businesses within transformative industries. These are primarily concentrated in the fields of Life Sciences, Healthcare Services, and Digital Health. The firm's approach integrates multi-generational family values, an entrepreneurial mindset, and institutional private equity disciplines to cultivate significant expertise in its investment areas.The firm's portfolio includes notable investments and acquisitions such as Radius Health, a specialty biopharmaceutical company, and Paratek Pharmaceuticals, which combined with Radius Health to form a scaled specialty pharmaceutical platform. Other investments include HerMD (Series A), Santhera (Post IPO), and Zwift (Series A). B-FLEXION has also acquired companies like Allergy Partners, Strategic Investment Group, and Vantage Infrastructure, demonstrating its broad investment strategy across various sectors.B-FLEXION is owned by Ernesto Bertarelli and traces its roots back to a biopharmaceutical company that evolved over three generations, with an investment track record spanning more than two decades. The firm places a strong emphasis on its people, considering the targeting and development of talent as a strategic imperative. Its leadership team includes Ernesto Bertarelli as Chairman, Sarah Crawford as Group CFO, Partner and Member of the Board, and Ranjani Kearsley as Head of Asset Management Investments, among other experienced professionals.

Bavarian Capital Management

Bavarian Capital Management

Limited PartnerGermany

Bavarian Capital Management is a Munich-based family office investment firm that primarily focuses on private equity and venture capital investments. The firm engages in direct investments, partnering closely with founders by offering coaching and strategic guidance to help portfolio companies achieve their goals, which may include a takeover or an IPO. While the firm initially engaged in active portfolio management encompassing listed equities, foreign exchange (FX) dealing, Contracts for Difference (CFDs), and various options strategies, its business model has evolved to almost exclusively concentrate on private equity and venture capital.The firm was founded in 2001, although its active portfolio management began in 2014. The founder, Niko Dimitrov, brings extensive experience from a distinguished career in finance. He began his journey in August 1983 at the US American investment bank Kidder Peabody & Co. in Paris, following his graduation from the European Business School and an MBA from the American University in Washington D.C. From 1985 to 1995, Dimitrov worked at Morgan Stanley in London, gaining significant experience in institutional sales and high-net-worth departments, where he also started his venture capital and private equity endeavors as a business angel.Bavarian Capital Management's diverse portfolio includes investments across various sectors. Notable companies include SILKFRED, an online platform for independent fashion brands; PAEDI PROTECT AG, specializing in skincare products for sensitive skin; MYNARIC, a developer of laser communication equipment for aerial and space networks; 4TIITOO, a pioneer in natural user experience software based on eye tracking and AI; QARMA, which utilizes proprietary algorithms to measure global market sectors; TABLECROWD, a business networking platform; INVITROCUE, a provider of bio-analytic solutions for cell-based testing and digital pathology; and SILBERTREU 24h Care.The firm's investment strategy is sector-agnostic, with a history of transactions in aerospace, e-commerce, technology, fashion, consumer goods, communication, healthcare, and food and beverage sectors. They often look to co-invest with other family offices, institutional, and individual investors. Niko Dimitrov's deep financial background and experience as a business angel underpin the firm's approach to nurturing and growing its portfolio companies.

Berggruen Holdings

Berggruen Holdings

InvestorUnited States2.0B AUM

Berggruen Holdings is a global investment firm that serves as the direct investment vehicle of the Nicolas Berggruen Charitable Trust. The firm deploys proprietary capital across a diverse range of industries, continents, and asset classes, including direct private equity, real estate, alternative energy, financial instruments, and basic industry startups. They are known for their long-term, value-oriented investment approach, often building their portfolio organically through acquisitions and strategic partnerships. Berggruen Holdings is prepared to invest up to $200 million in a single transaction, demonstrating significant financial capacity and flexibility due to operating without external capital commitments or fund structures.Founded in 1984 by Nicolas Berggruen, the firm originated from his early investments in real estate and public stocks, utilizing his trust fund. Over the past two decades, Berggruen Holdings has made hundreds of investments globally, expanding into private equity, venture capital, and hedge funds. Nicolas Berggruen, a German-American billionaire investor and philanthropist, established the firm to manage his investments and later co-founded the Berggruen Institute, a non-profit think tank focused on governance, economic systems, and technology.The firm's portfolio showcases a wide array of investments. Notable recent ventures include Chemify (2025) in the healthcare sector, and earlier investments in Story (2023), iLoF (2022), and prePO (2022) in seed and Series A rounds. Berggruen Holdings has also made significant acquisitions such as TLC Companies (2019) and has a strong presence in real estate, including a partnership with Firebird Grove for multi-family properties in New York City (2020) and extensive holdings in Berlin and Portland, Oregon. Other past investments span diverse areas like International Education Corporation, Thunder Funding (transportation factoring), and Telnic (a TLD operator).Berggruen Holdings is led by a seasoned team, with Nicolas Berggruen as Investment Advisor and Justin Topilow as Chief Executive Officer. The leadership also includes Koonal Gandhi as Chief Investment Officer and Eleanor Hsu as Managing Director of Investments. The team's global reach is evident through Managing Directors specializing in regions such as Global Real Estate, Germany, Europe, France, Turkey, and India, reflecting the firm's diversified international investment strategy and expertise across various asset classes and geographic markets.

Buono Ventures

Buono Ventures

InvestorItaly

Buono Ventures is a family office platform based in Milan, Italy, operating with both an advisory and a private equity investment arm. The firm's mission is to identify sustainable listed and private investments that offer a long-term horizon and a robust risk-return profile. Their investment approach encompasses direct minority investments, direct active investments with a governance role, and strategic commitments to private equity, private debt, and secondary funds. Buono Ventures actively seeks opportunities in profit-making companies with attractive growth profiles, often participating in third-party promoted club deals.The firm was founded in 2018 by Francesco de Mojana di Cologna. After a distinguished career, including a partnership at Permira, Francesco de Mojana di Cologna established Buono Ventures as a family office platform. His vision was to create an investment vehicle with an active presence across Southern Europe, the United States, the Middle East, and Israel, leveraging his extensive experience of over three decades in diverse sectors and geographical areas.Buono Ventures demonstrates a keen interest in sectors such as consumer, sports and leisure, business services, healthcare, food service, and real estate. Their portfolio includes notable investments like Healthy Poke, a company within the Restaurants and Bars industry, and K Health, a recognized HealthTech unicorn. Additionally, the firm was an investor in Hippocrates Holding, which was subsequently acquired. Buono Ventures typically deploys investment tickets ranging from €3-5 million, frequently collaborating with entrepreneurs and other club deal investors rather than pursuing fully controlling stakes.The leadership of Buono Ventures is anchored by its founder, Francesco de Mojana di Cologna, an Italian investor with a strong background in private equity, holding degrees from Bocconi University and Columbia Business School. The firm also plays a role in the Buono Investment Club (BIC), a club deal platform co-founded by Francesco De Mojana alongside other former Permira professionals such as Carlos Mallo, Nicola Volpi, and Antonio Zaccheo. This collaborative network brings together a wealth of international expertise and experience from senior leaders in various industries, enhancing the firm's ability to support portfolio companies and entrepreneurs.

Cara Investment

Cara Investment

InvestorGermany

Cara Investment is a prominent private asset manager and single-family office headquartered in Frankfurt, Germany, with a strategic presence in London. The firm is dedicated to safeguarding, managing, and expanding wealth by combining established values with contemporary financial expertise. They adopt a dynamic approach to asset management, integrating traditional methodologies with innovative strategies to generate long-term value across a diverse range of asset classes.Established in 2010, Cara Investment was founded to oversee a substantial fortune accumulated through commercial real estate development and sustained property ownership. The firm operates with a permanent capital base, which enables long-term asset management and the flexible deployment of capital, specifically aimed at preserving and enhancing multi-generational wealth.Cara Investment strategically allocates capital across a comprehensive global portfolio that encompasses traditional asset classes such as public equities and fixed income, alongside alternative investments including private equity, hedge funds, and real estate funds. Their real estate holdings feature prime assets situated in key gateway markets across Europe and the United States, with a focus on long-term ownership and sustainable returns. A notable project in their portfolio is The Bank Building in Washington D.C., which Cara acquired in 2017 and subsequently renovated into a prestigious office building through a joint venture with LPC. The firm also commits capital to funds managed by distinguished entities such as Silverfleet Capital, The Carlyle Group, and Montana Capital Partners.The firm is committed to developing and maintaining a resilient and sustainable investment program, prioritizing human capital and intellectual honesty. Cara Investment is supported by a dedicated team of investment professionals who possess extensive expertise in critical areas such as asset allocation, manager selection, and portfolio construction. This team, which includes Managing Directors, a Co-CIO, and a Head of Real Estate, collectively navigates the complexities of the financial landscape with a meticulously curated global portfolio.

Understanding Healthcare Private Equity Firms in Europe

Healthcare private equity firms in Europe are pivotal players in the financial landscape, offering unique investment opportunities within the healthcare sector. This curated directory features 18 notable investors, each bringing a strategic focus on healthcare-related assets. These firms are defined by their specialization in healthcare investments, ranging from pharmaceuticals and biotechnology to healthcare services and medical devices. With a keen eye on innovation and growth, these firms play a crucial role in the evolution and advancement of healthcare industries across Europe.

Investment Strategies and Focus Areas

Target Sectors and Opportunities

Healthcare private equity firms typically concentrate on sectors with high growth potential and resilience to economic fluctuations. Their investment strategies often revolve around pharmaceuticals, biotechnology, healthcare services, and medical technology. By focusing on these areas, firms can leverage emerging trends such as digital health, personalized medicine, and aging populations, which continue to drive demand for innovative healthcare solutions. The firms in this directory are adept at identifying and nurturing companies that promise substantial returns through strategic growth and operational improvements.

Geographic Focus in Europe

The geographic presence of these healthcare private equity firms spans across Europe, with significant activity in major markets such as the United Kingdom, Germany, France, and the Nordic countries. Their strategic positioning allows them to tap into regional expertise and local market dynamics, providing them with a competitive advantage in sourcing and executing deals. By maintaining a robust presence in key European markets, these firms can respond swiftly to opportunities and challenges within the healthcare sector.

Significance for LPs and Deal Professionals

Value Creation and Risk Mitigation

For Limited Partners (LPs) and deal professionals, investing in healthcare private equity firms offers a unique combination of value creation and risk mitigation. These firms have a proven track record of enhancing portfolio company performance through strategic guidance, operational enhancements, and access to industry networks. By investing in companies with solid growth potential, they can deliver substantial returns while mitigating risks associated with market volatility.

Strategic Partnerships and Industry Insights

The curated directory of healthcare private equity firms provides LPs and deal professionals with access to strategic partnerships and industry insights. Engaging with these firms enables stakeholders to leverage their expertise, gain deeper industry knowledge, and identify lucrative investment opportunities. The collaborative approach adopted by these firms ensures that investments are aligned with broader industry trends and regulatory changes, enhancing the potential for success.

Conclusion

Healthcare private equity firms in Europe represent a vital segment of the investment landscape, offering specialized expertise and strategic focus on high-growth sectors. With a presence in key European markets and a commitment to innovation, these firms are well-positioned to capitalize on emerging healthcare trends. For LPs and deal professionals, engaging with these investors presents an opportunity to partake in the transformative potential of the healthcare industry, driving value creation and sustainable growth.